Literature DB >> 17510301

Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry.

Giancarlo la Marca1, Sabrina Malvagia, Elisabetta Pasquini, Marzia Innocenti, Maria Alice Donati, Enrico Zammarchi.   

Abstract

BACKGROUND: The expansion of newborn screening programs has increased the number of newborns diagnosed with inborn errors of metabolism in the presymptomatic phase, but it has also increased the number of costly, stress-producing false-positive results. Because propionylcarnitine (C3) is one of the analytes most frequently responsible for false-positive results, we aimed to develop a rapid liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to identify free methylmalonic (MMA) and 3-OH propionic (3OH-PA) acids in blood spots.
METHODS: We studied newborn screening spots from 250 healthy controls; 124 from infants with abnormal C3, of whom only 5 (4%) were truly affected; 124 from infants with altered isolated methylmalonylcarnitine; and 4 from clinically diagnosed patients. Whole blood was eluted from a 3.2-mm dried blood spot by a CH(3)CN/H(2)O 7:3 and 5 mL/L formic. This extract was injected into a LC-MS/MS equipped with pneumatically assisted electrospray without derivatization. Total analysis time was 5 min per sample.
RESULTS: The assays were linear up to 3300 nmol/L for both metabolites. Intra- and interassay imprecision data were 3.6%-8% and 3.1%-6%, respectively, for MMA and 5.2%-20% and 3.6%-17% for 3OH-PA. Limit of detection and limit of quantitation were 1.95 and 4.2 micromol/L, respectively, for MMA and 8 and 10 micromol/L for 3OH-PA. The recoveries were 92.9%-106.1%. No deterioration was noted on the columns after 500 chromatographic runs. If the new method had been used as a 2nd-tier test for the 124 samples, only the 5 true positives would have been recalled for additional samples, and the positive predictive value would have been 100%.
CONCLUSIONS: This method has the potential to markedly reduce false-positive results and the associated costs and anxiety. It may also be suitable for diagnosing and routinely monitoring blood spots for methylmalonic aciduria and propionic acidemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510301     DOI: 10.1373/clinchem.2007.087775

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  24 in total

1.  Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry.

Authors:  James J Pitt
Journal:  Clin Biochem Rev       Date:  2009-02

2.  Simple, Fast, and Simultaneous Detection of Plasma Total Homocysteine, Methylmalonic Acid, Methionine, and 2-Methylcitric Acid Using Liquid Chromatography and Mass Spectrometry (LC/MS/MS).

Authors:  Xiaowei Fu; Yan-Kang Xu; Penny Chan; Paul K Pattengale
Journal:  JIMD Rep       Date:  2013-02-15

3.  Correction of methylmalonic aciduria in vivo using a codon-optimized lentiviral vector.

Authors:  Edward S Y Wong; Chantelle McIntyre; Heidi L Peters; Enzo Ranieri; Donald S Anson; Janice M Fletcher
Journal:  Hum Gene Ther       Date:  2014-04-02       Impact factor: 5.695

4.  Useful second-tier tests in expanded newborn screening of isovaleric acidemia and methylmalonic aciduria.

Authors:  Yosuke Shigematsu; Ikue Hata; Go Tajima
Journal:  J Inherit Metab Dis       Date:  2010-05-04       Impact factor: 4.982

5.  High incidence of maternal vitamin B12 deficiency detected by newborn screening: first results from a study for the evaluation of 26 additional target disorders for the German newborn screening panel.

Authors:  Gwendolyn Gramer; Junmin Fang-Hoffmann; Patrik Feyh; Glynis Klinke; Peter Monostori; Jürgen G Okun; Georg F Hoffmann
Journal:  World J Pediatr       Date:  2018-06-15       Impact factor: 2.764

6.  Expansion of the Phenotypic Spectrum of Propionic Acidemia with Isolated Elevated Propionylcarnitine.

Authors:  Gerarda Cappuccio; Paldeep S Atwal; Taraka R Donti; Kiki Ugarte; Nadia Merchant; William J Craigen; V Reid Sutton; Sarah H Elsea
Journal:  JIMD Rep       Date:  2016-11-30

7.  The national Austrian newborn screening program - eight years experience with mass spectrometry. past, present, and future goals.

Authors:  David C Kasper; Rene Ratschmann; Thomas F Metz; Thomas P Mechtler; Dorothea Möslinger; Vassiliki Konstantopoulou; Chike B Item; Arnold Pollak; Kurt R Herkner
Journal:  Wien Klin Wochenschr       Date:  2010-10-15       Impact factor: 1.704

8.  Improving the Speed and Selectivity of Newborn Screening Using Ion Mobility Spectrometry-Mass Spectrometry.

Authors:  James N Dodds; Erin S Baker
Journal:  Anal Chem       Date:  2021-12-01       Impact factor: 6.986

9.  Analysis of methylcitrate in dried blood spots by liquid chromatography-tandem mass spectrometry.

Authors:  Osama Y Al-Dirbashi; Nathan McIntosh; Christine McRoberts; Larry Fisher; Mohamed S Rashed; Nawal Makhseed; Michael T Geraghty; Tomofumi Santa; Pranesh Chakraborty
Journal:  JIMD Rep       Date:  2014-07-06

10.  Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias.

Authors:  Sabrina Malvagia; Christopher A Haynes; Laura Grisotto; Daniela Ombrone; Silvia Funghini; Elisa Moretti; Kathleen S McGreevy; Annibale Biggeri; Renzo Guerrini; Raquel Yahyaoui; Uttam Garg; Mary Seeterlin; Donald Chace; Victor R De Jesus; Giancarlo la Marca
Journal:  Clin Chim Acta       Date:  2015-09-11       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.